Swiss Neonatal Network & Follow-up Group

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The chief aim of the Swiss Neonatal Network \& Follow-Up Group (SwissNeoNet) is to maintain and / or improve the quality and safety of medical care for high-risk newborn infants and their families in Switzerland through a coordinated program of research, education and collaborative audit. In support of its aim, SwissNeoNet hosts the official medical quality register for the Swiss level III and level IIB units. Participation for these units is mandatory according to the intercantonal declaration for Highly Specialized Medicine (HSM) of September 22, 2011 and the Society's Standards for Levels of Neonatal Care in Switzerland.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 28 days
Healthy Volunteers: f
View:

• All Swiss live-born infants below 32 weeks gestational age or 1501g birth weight

• All Swiss live-born infants between 32 0/1 and 33 6/7 weeks gestational age that are above 1500g birth weight

• Infants between 35 0/7 and 42 6/7 weeks' gestational age with moderate or severe encephalopathy due to perinatal asphyxia

Locations
Other Locations
Switzerland
Department of Neonatology
RECRUITING
Zurich
Contact Information
Primary
Mark Adams, PhD
mark.adams@usz.ch
+41432533034
Backup
Dirk Bassler, MD, MSc
dirk.bassler@usz.ch
Time Frame
Start Date: 2000-01-01
Estimated Completion Date: 2050-12-31
Participants
Target number of participants: 1000
Treatments
Minimal Neonatal Dataset MNDS
All Swiss live-born infants below 32 weeks gestational age or 1501g birth weight
Below 34, B34
All Swiss live-born infants between 32 0/1 and 33 6/7 weeks gestational age that are above 1500g birth weight
Swiss Asphyxia and Cooling Registry, ASP
Infants between 35 0/7 and 42 6/7 weeks' gestational age with moderate or severe encephalopathy due to perinatal asphyxia
Related Therapeutic Areas
Sponsors
Collaborators: Department of Neuropaediatrics, University Hospital Berne, Switzerland, Department of Child Development, Children's Hospital St. Gallen, Switzerland, Department of Pediatrics, San Giovanni Hospital Bellinzona, Switzerland, Department of Neonatology, Cantonal Hospital St. Gallen, Switzerland, Department of Neuropaediatrics and Developmental Medicine, University of Basel Children's Hospital (UKBB), Switzerland, Social Pediatrics Center, Cantonal Hospital Winterthur, Switzerland, Department of Pediatrics, Cantonal Hospital Muensterlingen, Switzerland, Department of Neonatology, University Hospital Berne, Switzerland, Department of Neonatology, Children's Hospital Chur, Switzerland, University Children's Hospital, Zurich, Department of Neonatology, Cantonal Hospital Winterthur, Switzerland, Neonatal and Paediatric Intensive Care Unit, Children's Hospital of Lucerne, Switzerland, Department of Neuropediatrics, Cantonal Hospital Fribourg, Switzerland, Department of Neonatology, University Hospital Geneva (HUG), Switzerland, Department of Neonatology, University of Basel Children's Hospital (UKBB), Switzerland, Department of Neuropaediatrics, Children's Hospital Chur, Switzerland, Department of Neuropaediatrics, Children's Hospital of Lucerne, Switzerland, Development and Pediatric Neurorehabilitation Center, Biel, Switzerland, Department of Pediatrics, Cantonal Hospital Neuchatel, Switzerland, Department of Neonatology, Children's Clinic, Cantonal Hospital Aarau, Switzerland, University of Lausanne Hospitals, Neonatal and Paediatric Intensive Care Unit, Children's Hospital St. Gallen, Switzerland, Division of Development and Growth, University Hospital Geneva (HUG), Switzerland, Department of Neuropaediatrics, Children's Clinic, Cantonal Hospital Aarau, Switzerland, University Hospital, Zürich
Leads: Swiss Neonatal Network

This content was sourced from clinicaltrials.gov

Similar Clinical Trials